Company intelligence / Profile preview

Homa Pharmed

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Homa Pharmed is a leading Iranian pharmaceutical and medical device company specializing in treatments for cancer, infertility, and inflammatory conditions. They have introduced several biotechnological and biological drugs, and in 2019 expanded to a modern facility for manufacturing injectable medicines, including hyaluronic acid-based medical devices. The company is a significant player in Iran and the Middle East for injectable therapies.[1][2]

Therapeutic areas: OncologyImmunologyWomen's Health
Modalities: BiologicSmall moleculeMedical deviceHyaluronic acid-based products
Industry: Biotech

Beyond the preview

Go deeper on Homa Pharmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homa Pharmed.

Explore the full profile